A RARE CASE OF NON-CLASSICAL TYPE OF CONGENITAL ADRENAL HYPERPLASIA IN A 27-YEAR-OLD FEMALE

Authors

  • Masab Ali Faisalabad Medical University, Faisalabad-Pakistan
  • Muhammad Husnain Ahmad Asian Medical Institute, Kant-Kyrgyzstan https://orcid.org/0009-0006-5248-0749
  • Zaid Ashraf Mirza Faisalabad Medical University, Faisalabad-Pakistan

DOI:

https://doi.org/10.55519/JAMC-02-12419

Keywords:

Non-classical congenital adrenal hyperplasia, Hyperandrogenism, ACTH stimulation test, Secondary Amenorrhea, Congenital adrenal Hyperplasia

Abstract

This case report presents the case of a 27-year-old female patient with a complex clinical presentation, diagnosed with nonclassical congenital adrenal hyperplasia (NCCAH). The patient presented with a constellation of symptoms including hirsutism, acne, hyperpigmentation, amenorrhea, frontal baldness, and renal stones, posing diagnostic challenges. Comprehensive evaluation revealed NCCAH, emphasizing the importance of considering this condition in cases of hyperandrogenism. Treatment with oral dexamethasone and oral contraceptive pills resulted in gradual symptom improvement. This case underscores the necessity for thorough clinical assessment and awareness of NCCAH as a differential diagnosis in patients with hyperandrogenic symptoms.

References

Witchel SF, Azziz R. Nonclassic Congenital Adrenal Hyperplasia. Int J Pediatr Endocrinol 2010;2010:625105.

Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Moran C, Oberfield S, et al. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update 2017;23(5):580–99.

Adriaansen BPH, Schröder MAM, Span PN, Sweep FCGJ, van Herwaarden AE, Claahsen-van der Grinten HL. Challenges in treatment of patients with non-classic congenital adrenal hyperplasia. Front Endocrinol (Lausanne) 2022;13:1064024.

Smet ME, McLennan A. Rotterdam criteria, the end. Australas J Ultrasound Med 2018;21(2):59–60.

Escobar-Morreale HF, Sanchón R, San Millán JL. A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs. J Clin Endocrinol Metabol 2008;93(2):527–33.

Shaw ND, Histed SN, Srouji SS, Yang J, Lee H, Hall JE. Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women. J Clin Endocrinol Metab 2010;95(4):1955–61.

Claahsen - van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, et al. Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management. Endocr Rev 2021;43(1):91.

UpToDate [Internet]. www.uptodate.com. [cited 2023 Aug]. Available from: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-classic-congenital-adrenal-hyperplasia-due-to-21-hydroxylase-deficiency-in-infants-and-children

Livadas S, Dracopoulou M, Dastamani A, Sertedaki A, Maniati-Christidi M, Magiakou AM, et al. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of theCYP21A2gene. Clin Endocrinol 2014;82(4):543–9.

Livadas S, Bothou C. Management of the Female with Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach. Front Endocrinol (Lausanne) 2019;10:366.

Trapp CM, Oberfield SE. Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update. Steroids 2012;77(4):342–6.

McKay LI, Cidlowski JA. Physiologic and Pharmacologic Effects of Corticosteroids. In: Holland-Frei Cancer Medicine 6th edition [Internet]. BC Decker; 2003 [cited 2024 Aug]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK13780/

Downloads

Published

2024-06-30